Signal category
Understand market structure changes, launch dynamics, and access shifts that affect asset and company valuations.
Pricing, access, demand, and commercialization trends that influence revenue outlooks and investment theses.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.
AstraZeneca reported a 13% increase in total revenue for Q1 2026, driven by strong product sales and positive readouts from new molecular entities (NMEs).
Company
Eli Lilly
Asset
Foundayo
Indication
Obesity / Pharmacotherapy
Status
Under Review
Signal Score
8.4
CVS Caremark will cover Foundayo starting June 1 and Zepbound from October 1, allowing eligible patients to pay as low as $25 monthly.
Signal Score
8.2
Healthcare providers in South Africa support the Dual Prevention Pill (DPP) for HIV and pregnancy prevention but express concerns about daily dosing and side effects.